Magnetic resonance imaging-guided radiation for limited belly tumors
Part of Cancer, Digestive system clinical trials.
This trial tests a precise type of radiation that is adjusted each day using MRI to target up to 5 tumors that have spread in the belly lining. It aims to treat these limited tumors with less damage to healthy tissue, possibly offering an option when other treatments have been tried.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are generally able to care for yourself (able to do light activities and walk around)
- Your doctor expects you to live at least 6 more months
- You have 5 or fewer tumors seen on MRI that have spread in your belly lining
- You have not had radiation therapy to your belly in the last 6 months
- You have had earlier treatment for these tumors, like surgery or heated chemotherapy
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether high-precision radiation (SBRT) can improve outcomes for people with up to 5 small, stable metastases from certain cancers, compared to usual palliative care. It is for those whose disease is not growing after current chemotherapy.
This trial is testing a precise type of radiation therapy (called SBRT) for people with sarcoma in the belly or pelvic area. The goal is to see if this targeted radiation can help shrink or control the tumor before surgery, and it may be an option if you haven't had radiation to that area before.
This feasibility study tests whether MRI-guided, highly focused radiation can be safely delivered to tumors in the abdomen or central lung. It may help patients with a small number of metastases by aiming treatment more precisely and gathering detailed outcomes for future care.
This Phase 1 study tests an “adaptive” form of focused radiation (SBRT) for cancers that have spread in the abdomen or pelvis. It aims to treat metastatic tumor spots safely while adjusting the plan as needed during treatment.
This Phase 2 trial tests an MRI-guided, highly targeted radiation treatment (SBRT) for tumors that have spread to the liver. It may help shrink 1–3 liver metastases while using imaging to better guide treatment.
This trial tests a single, high-dose radiation treatment (SBRT) guided by MRI for people with colorectal cancer that has spread to the liver. The goal is to see if this precise, one-time treatment can effectively control liver tumors while protecting nearby organs.
Hear when a new Peritoneal Carcinomatosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.